Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “URTICARIA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02166151
What this trial is testing

Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria

Who this might be right for
Chronic Idiopathic Urticaria
Rabin Medical Center 20
Not applicableStudy completedNCT02833675
What this trial is testing

Determination of Specific Biomarkers of Angioneurotic Crisis

Who this might be right for
Angioedema
University Hospital, Grenoble 120
Testing effectiveness (Phase 2)Study completedNCT03926611
What this trial is testing

This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 311
Large-scale testing (Phase 3)Study completedNCT05032157
What this trial is testing

Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 455
Testing effectiveness (Phase 2)Ended earlyNCT04128371
What this trial is testing

Mepolizumab in Episodic Angioedema With Eosinophilia

Who this might be right for
EosinophiliaAngioedema
National Institute of Allergy and Infectious Diseases (NIAID) 5
Post-approval studies (Phase 4)Study completedNCT01467947
What this trial is testing

Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 46
Testing effectiveness (Phase 2)Study completedNCT03749135
What this trial is testing

Dupilumab in Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous UrticariaRecurrent Angioedema
Charite University, Berlin, Germany 72
Not applicableAvailableNCT07216378
What this trial is testing

Treatment of Angioedema Attacks in Pediatric (Ages 2-11) Post-Trial and Naive Patients With HAE With Sebetralstat

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd.
Testing effectiveness (Phase 2)Study completedNCT02031679
What this trial is testing

Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines

Who this might be right for
Chronic Idiopathic Urticaria
Johns Hopkins University 38
Testing effectiveness (Phase 2)Study completedNCT04109313
What this trial is testing

An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSU

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 229
Testing effectiveness (Phase 2)Active Not RecruitingNCT06931405
What this trial is testing

Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

Who this might be right for
Chronic Inducible UrticariaChronic Spontaneous Urticaria
Blueprint Medicines Corporation 105
Early research (Phase 1)Study completedNCT05461456
What this trial is testing

Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%

Who this might be right for
Atopic DermatitisAtopic Dermatitis EczemaAtopic Rash+9 more
OrchestratePharma GmbH 12
Not applicableStudy completedNCT03917680
What this trial is testing

Evaluation of New Markers in Type 3 Angioedema

Who this might be right for
Angio Edema
Brugmann University Hospital 32
Not applicableLooking for participantsNCT07293364
What this trial is testing

Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 514
Early research (Phase 1)Not Yet RecruitingNCT07684560
What this trial is testing

Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2).

Who this might be right for
Chronic Spontaneous Urticaria (CSU)Healthy Volunteers
AlphaMol Science Ltd. (Shanghai) 48
Large-scale testing (Phase 3)Active Not RecruitingNCT06042478
What this trial is testing

Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 470
Testing effectiveness (Phase 2)Study completedNCT01095497
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration

Who this might be right for
Hereditary Angioedema
Shire 26
Not applicableEnrolling By InvitationNCT07632040
What this trial is testing

Pseudoallergen-Free and Low-Histamine Diet in Adolescents With Chronic Spontaneous Urticaria

Who this might be right for
Pediatric Chronic Spontaneous Urticaria
Istanbul University 120
Not applicableLooking for participantsNCT06838143
What this trial is testing

Ilaris NIS in Korea

Who this might be right for
Hereditary Periodic Fever SyndromesCryopyrin-associated Periodic Syndromes (CAPS)Colchicine Resistance Familial Mediterranean Fever (crFMF)+3 more
Novartis Pharmaceuticals 25
Testing effectiveness (Phase 2)Ended earlyNCT05055258
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II

Who this might be right for
Angioedema, Hereditary, Types I and II
KalVista Pharmaceuticals, Ltd. 33
Next Page